Chemotherapy-induced Symptoms in Sarcoma Patients and the Impact of Tumor Burden

University of Pittsburgh

Status: Completed

Conditions: Soft Tissue Sarcoma

Treatments: Other: Questionnaires

Study type: Observational

Funder types: Other

Identifiers

NCT01136824

10-046

Details and patient eligibility

About

Assessments (survey data) in this study are designed to sample the symptom burden of patients undergoing adjuvant and neoadjuvant chemotherapy in the hospital. There will be no change in the treatment plan for these patients.

Enrollment: 11 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who are receiving doxorubicin plus ifosfamide (AI)

Exclusion criteria

• There is no exclusion criteria

Trial design

11 participants in 1 patient group

Sarcoma Subjects

Description:

Soft tissue sarcoma patients treated with the adjuvant and neoadjuvant chemotherapy protocol of doxorubicin plus ifosfamide (AI)

Treatment:

Other: Questionnaires